Skip to content

Egger, Klemens

2 papers in the library · publishing 2025

Papers

Meditation, psychedelics, and brain connectivity: A randomized controlled resting-state fMRI study of N,N-dimethyltryptamine and harmine in a meditation retreat

Universität Zürich, ZORA September 29, 2025 Egger, Klemens, Meling, Daniel, Polat, Firuze et al.

Meditation alone increased network segregation in the brain, while a combination of meditation and a DMT–harmine formulation (an ayahuasca-inspired compound) increased connectivity within the visual network and between visual and attention networks. Forty meditation practitioners participated in a 3-day retreat and were randomly assigned to receive either placebo or buccal DMT–harmine. Brain scans taken before and after showed no lasting disruption of cortical gradients, indicating brain organization returned to typical patterns shortly after the psychedelic experience. These distinct neural effects suggest meditation and psychedelic-augmented meditation engage different mechanisms, warranting further study of their combined therapeutic potential.

Neurobehavioral and Molecular Pharmacology of Pharmahuasca ($\textit{N,N}$-dimethyltryptamine (DMT) and Harmine) in Humans – A Combined Neuropharmacological and Brain Imaging Approach

June 4, 2025 Egger, Klemens

Ayahuasca is an Amazonian plant medicine used for millennia by indigenous people; its primary chemical constituents are DMT and harmine. This thesis investigates a simplified, standardized formulation of DMT and harmine to understand their neurobehavioral and molecular pharmacology. A preclinical study in rodents showed that harmine slows DMT metabolism in the brain, but no significant differences were found in glucose metabolism or serotonin 2A receptor binding. A human study using a novel oromucosal application reliably induced psychedelic effects with a favorable adverse effect profile and revealed bidirectional drug-drug interactions.